As the new year unfolds, the leading charging solution brand TESSAN proudly announces an inspiring collaboration with the ...

A new study published in the BMJ Thorax journal showed that obstructive sleep apnea syndrome (OSAS) may be linked to an ...

The obesity medication Zepbound can be used on-label to treat obstructive sleep apnea in adults with obesity, the FDA ...

Obesity is more than a cosmetic concern. It’s a chronic disease that can be treated with drugs like semaglutide (Wegovy) and ...

VP Patrick Dennis Gamble purchased 17,000 shares of the business’s stock in a transaction on Thursday, December 26th. The ...

The Food and Drug Administration approved Eli Lilly’s weight-loss drug Zepbound on Dec. 27 to treat sleep apnea, a common but ...

Andi Dorfman is settling into her life as a new mom and after one week at home, she is ready to share her daughter's birth ...

The U.S. Food and Drug Administration (FDA) has approved Zepbound, a prescription weight-loss medication, as the first drug ...

Nyxoah's disrupting Genio implant is likely to revolutionize Obstructive Sleep Apnea, and FDA's decision is expected in Q1 ...

purchased a new stake in shares of AdaptHealth during the second quarter worth $115,000 ... The company provides sleep ...

By aiding weight loss, Zepbound can improve symptoms of obstructive sleep apnea (OSA) in people with obesity — but CPAP ...